After authorising Pfizer/BioNTeach’s vaccine for emergency use against the novel coronavirus, the United States also gave approval to Moderna Inc’s coronavirus vaccine on Friday.
The development was announced by the US Food and Drug Administration (FDA). The emergency use authorization would allow the Moderna COVID-19 Vaccine to be distributed in the U.S. for mass immunisation.
According to the article published in CNN : “There are a few key differences(between Pfizer’s and Moderna’s vaccines), most importantly, Moderna’s vaccine can be stored in normal freezers and does not require a super-cold transportation network, making it more accessible for smaller facilities and local communities.”
Moderna is a biotech company based in Cambridge, Massachusetts. The United States has remained the most affected country during the Covid-19 pandemic. The virus has killed more than 300,000 Americans while infecting almost 18 million of the US population.